INO vs ZBH · $88.0M cap vs P/E 23, rev $4.26B
Inovio Pharmaceuticals Inc (INO) versus Zimmer Biomet Holdings Inc (ZBH) — a side-by-side from cached financials, not a winner call.
Inovio Pharmaceuticals Inc (INO) is a biotechnology company listed on US.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
Latest reported INO revenue for 2026-06-30 was $0. Net income was -$6.0M. INO currently screens at market cap $88.0M.
Latest reported ZBH revenue for 2026-06-30 was $4.26B. Net income was $436.5M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
INO currently screens at market cap $88.0M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Not investment advice. Open the INO and ZBH stock pages for the full models.
Not investment advice.